These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 3386426)

  • 1. Hyperlipidemia: treatment with lipid-lowering agents.
    LaRosa JC
    Md Med J; 1988 May; 37(5):401-6. PubMed ID: 3386426
    [No Abstract]   [Full Text] [Related]  

  • 2. Lipid lowering activity of Eclipta prostrata in experimental hyperlipidemia.
    Kumari CS; Govindasamy S; Sukumar E
    J Ethnopharmacol; 2006 May; 105(3):332-5. PubMed ID: 16406413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Lipid-lowering drugs].
    Fortschr Med Suppl; 1988; 46():13-4. PubMed ID: 2905325
    [No Abstract]   [Full Text] [Related]  

  • 4. [Can we really reach our goals? Arguments for aggressive lipid lowering].
    Internist (Berl); 1999 Sep; 40(9 Suppl Argumente):1-8. PubMed ID: 10528586
    [No Abstract]   [Full Text] [Related]  

  • 5. Improvement in current approaches to lipid lowering.
    Ansell BJ
    Am Fam Physician; 2002 Mar; 65(5):783, 786-7. PubMed ID: 11898952
    [No Abstract]   [Full Text] [Related]  

  • 6. [Fibrates in the treatment of hyperlipidemia].
    Kłosiewicz-Latoszek L; Szostak WB
    Wiad Lek; 1993 Nov; 46(21-22):872-6. PubMed ID: 7817584
    [No Abstract]   [Full Text] [Related]  

  • 7. [Role of hyperlipidemia and its treatment].
    Ouellet A
    Union Med Can; 1991; 120(3):238-43. PubMed ID: 1866844
    [No Abstract]   [Full Text] [Related]  

  • 8. A vote of no confidence in the precision of the estimated cost-effectiveness of lipid lowering.
    Wilcock M
    Br J Gen Pract; 2000 Nov; 50(460):917-8. PubMed ID: 11141882
    [No Abstract]   [Full Text] [Related]  

  • 9. Relation of the use of lipid-lowering medications prior to percutaneous coronary intervention to the incidence of intraprocedural adverse angiographic events.
    Ferguson MA; Romick BG; Carter LI; De Geare VS
    Am J Cardiol; 2005 Apr; 95(8):978-80. PubMed ID: 15820168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Guidelines for lipid-lowering therapy. Results of the 2d Consensus Conference of the European Atherosclerosis Society. Press conference. London, 6 May 1988].
    Fortschr Med Suppl; 1988; 46():1-22. PubMed ID: 2905324
    [No Abstract]   [Full Text] [Related]  

  • 11. [How sure is the combined lipid lowering?].
    Schäfer J
    MMW Fortschr Med; 2005 Jan; 147(1-2):56. PubMed ID: 15704576
    [No Abstract]   [Full Text] [Related]  

  • 12. Does lipid-lowering therapy slow progression of chronic kidney disease?
    Wheeler DC
    Am J Kidney Dis; 2004 Nov; 44(5):917-20. PubMed ID: 15492960
    [No Abstract]   [Full Text] [Related]  

  • 13. Lipid-lowering drugs: French prescribers under pressure.
    Prescrire Int; 2002 Oct; 11(61):158. PubMed ID: 12378750
    [No Abstract]   [Full Text] [Related]  

  • 14. Case 2. Hyperlipidemia.
    Chan S
    Can J Cardiol; 2001 May; 17 Suppl A():36A-7A. PubMed ID: 11381295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipid lowering treatment patterns and goal attainment in Nordic patients with hyperlipidemia.
    Svilaas A; Strandberg T; Eriksson M; Hildebrandt P; Westheim A
    Scand Cardiovasc J; 2008 Aug; 42(4):279-87. PubMed ID: 18609053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Why does adequate tolerance of a lipid-lowering agent play such an important role?].
    Mutschler E
    Fortschr Med; 1990; 108 Spec No 1():54-5. PubMed ID: 2245962
    [No Abstract]   [Full Text] [Related]  

  • 17. Stroke prevention with lipid-lowering therapy.
    Piechowski-Jozwiak B; Bogousslavsky J
    Expert Rev Neurother; 2004 Mar; 4(2):233-9. PubMed ID: 15853564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The beneficial effects of lipid-lowering drugs beyond lipid-lowering effects: a comparative study with pravastatin, atorvastatin, and fenofibrate in patients with type IIa and type IIb hyperlipidemia.
    Saklamaz A; Comlekci A; Temiz A; Caliskan S; Ceylan C; Alacacioglu A; Yesil S
    Metabolism; 2005 May; 54(5):677-81. PubMed ID: 15877299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug therapy for hyperlipidemia.
    Am Pharm; 1988 Mar; NS28(3):91-5. PubMed ID: 3285656
    [No Abstract]   [Full Text] [Related]  

  • 20. [Also elderly patients with hyperlipidemia and coronary disease need lipid lowering agents].
    Hellénius ML
    Lakartidningen; 2001 Sep; 98(39):4188-90. PubMed ID: 11680152
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.